The FDA announced on 2019-11-13 that Precision Dose Inc. voluntarily recalled Ranitidine Oral Solution due to CGMP deviations involving impurity N-nitrosodimethylamine (NDMA) found in the active pharmaceutical ingredient, according to FDA records.
How to tell if you have it
- Brand: Precision Dose
- Product: Ranitidine Oral Solution, USP, 150 mg/10 mL
- NDC: 68094-204-62; 10 mL x 30 Unit Dose Cups per case
- NDC: 68094-204-61; 10 mL x 100 Unit Dose Cups per case
- Unit Dose Cup NDC: 68094-204-59
- Lot number: 501290, Expiry: 11/30/19, NDC: 68094-204-61
- Lot number: 501326, Expiry: 11/30/19, NDC: 68094-204-62
- Lot number: 501501, Expiry: 11/30/19, NDC: 68094-204-62
- Lot number: 1592, Expiry: 4/30/20, NDC: 68094-204-62
- Lot number: 501679, Expiry: 4/30/20, NDC: 68094-204-61, 68094-204-62
The hazard
The recall addresses CGMP deviations where impurity N-nitrosodimethylamine (NDMA) was found in the API of Ranitidine Oral Solution, according to FDA records.
Context
GovInfoNow's records show Precision Dose Inc. has 6 other recalls on record since 2013-03-21. Other recent recalls of similar products include Precision Dose Glycopyrrolate Oral Solution Recall (2026-07-14), Precision Dose Acetaminophen Suspension Recall (2021-11-01), and Precision Dose Chlorhexidine Rinse Recall (2021-01-01). Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (2025-12-15), Direct Rx DULOXETINE D/R 30mg Caps Recall (2026-06-22), and Cipla Cinacalcet Tablets Recall (2025-11-14).